Jeffrey M. Jonas
2017
In 2017, Jeffrey M. Jonas earned a total compensation of $5.7M as President and Chief Executive Officer at Sage Therapeutics, a 189% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $504,000 |
|---|---|
| Option Awards | $4,632,658 |
| Salary | $600,000 |
| Other | $11,697 |
| Total | $5,748,355 |
Jonas received $4.6M in option awards, accounting for 81% of the total pay in 2017.
Jonas also received $504K in non-equity incentive plan, $600K in salary and $11.7K in other compensation.
Rankings
In 2017, Jeffrey M. Jonas' compensation ranked 1,555th out of 14,666 executives tracked by ExecPay. In other words, Jonas earned more than 89.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,555 out of 14,666 | 89th |
Division Manufacturing | 521 out of 5,770 | 91st |
Major group Chemicals And Allied Products | 138 out of 2,074 | 93rd |
Industry group Drugs | 100 out of 1,730 | 94th |
Industry Pharmaceutical Preparations | 79 out of 1,329 | 94th |
Source: SEC filing on April 27, 2018.
Jonas' colleagues
We found four more compensation records of executives who worked with Jeffrey M. Jonas at Sage Therapeutics in 2017.
News
Sage Therapeutics CEO Barry Greene's 2021 pay jumps 469% to $59M
April 28, 2022
Sage Therapeutics CEO Jeffrey Jonas' 2020 pay falls 53% to $4.7M
April 29, 2021
Sage Therapeutics CEO Jeffrey Jonas' 2019 pay rises 1% to $9.9M
April 29, 2020
Sage Therapeutics CEO Jeffrey Jonas' 2018 pay jumps 71% to $9.8M
April 25, 2019